Lupin Limited informed that it has received tentative approval from United States Food & Drug Administration for Efinaconazole topical solution, 10 per cent to market a generic equivalent of Jublia® topical solution, 10 per cent of Bausch Health Americas, Inc. This solution is used to cure Onychomycosis, a fungal infection caused in nails.